Rare Pediatric Disease designation

Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease
CP Wire
Fri, 03/16/18 - 09:37 am
Abeona Therapeutics
FDA
pediatrics
ABO-202
Rare Pediatric Disease designation
priority review vouchers